Skip to main content
Signal8

Allen Patricia L

SEC insider (Form 3/4/5 filer). CIK 0001348587. Director at Zenas BioPharma, Inc. (ZBIO). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in WALTHAM, MA.

Companies Allen Patricia L has filed insider reports for

  • Zenas BioPharma, Inc. (ZBIO): Director
Allen Patricia L profile photo

Allen Patricia L

CIK: 0001348587

Transaction Breakdown

Open Market Buys (P)4 (57.1%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Zenas BioPharma, Inc. logo
ZBIO

Zenas BioPharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Jun 15, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    18.5K shares-
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Feb 13, 2026
    Purchase
    Direct
    4.2K shares at avg. $26.36$110K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Feb 12, 2026
    Purchase
    Direct
    5K shares at avg. $26.50$133K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Feb 12, 2026
    Purchase
    Direct
    5K shares at avg. $23.77$119K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Feb 12, 2026
    Purchase
    Direct
    5.7K shares at avg. $24.34$139K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Jun 10, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    18.5K shares-
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Sep 12, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    18.5K shares-

1-7 of 7